ACADIA Pharmaceuticals Inc.

In News

ACADIA Pharmaceuticals: Another Bite At The Alzheimer's Apple (NASDAQ:ACAD) - Seeking Alpha

Seeking Alpha - Aug 24, 2026

Is ACADIA Pharmaceuticals (ACAD) Still Trading At A Discount As DAYBU Wins EU Approval? - Sahm

Sahm - Aug 26, 2026

Acadia Pharmaceuticals Reports Second Quarter 2026 Financial Results - Yahoo Finance

Yahoo Finance - Aug 04, 2026

ACADIA Pharmaceuticals Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Revelio Labs - Jul 29, 2026

Deutsche Bank Adjusts ACADIA Pharmaceuticals PT to $38 From $37, Maintains Buy Rating - marketscreener.com

marketscreener.com - Aug 25, 2026

Results: ACADIA Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - simplywall.st

simplywall.st - Aug 08, 2026

UBS raises Acadia Pharmaceuticals stock price target on trial optimism - Investing.com

Investing.com - Aug 17, 2026

Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis - BioSpace

BioSpace - Jul 20, 2026

ACADIA Pharmaceuticals Inc. Stock 12‑Month Price Target Cut to $33.05, Implies 17% Upside - TradingView

TradingView - Aug 14, 2026

CNBC Cures: Acadia Pharmaceuticals CEO on scaling rare and neuro-focused drugs - CNBC

CNBC - Mar 16, 2026

ACADIA Pharmaceuticals Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ACAD) 2026-08-05 - Seeking Alpha

Seeking Alpha - Aug 05, 2026

ACADIA Pharmaceuticals Q2 Earnings Call Highlights - Yahoo Finance

Yahoo Finance - Aug 04, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment